Lupin receives USFDA approval for Levothyroxine tablets
Lupin has received final USFDA approval for Levothyroxine Sodium tablets USP, 25 mcg, 50 mcg, 75 mcg, 88 mcg, 100 mcg, 112 mcg, 125 mcg, […]
Lupin has received final USFDA approval for Levothyroxine Sodium tablets USP, 25 mcg, 50 mcg, 75 mcg, 88 mcg, 100 mcg, 112 mcg, 125 mcg, […]
Shilpa Medicare has received final USFDA approval for Irinotecan HCL injection to market the same in US. The injection drug will be marketed in the […]
Alembic Pharmaceuticals has received final USFDA approval for Pramipexole Dihydrochloride extended-release tablets used for the treatment of Parkinson’s disease. The drug will be marketed in […]
Cadila has received final USFDA approval to market antipsychotic drug Aripiprazole tablets in US markets. The drug will be marketed in the strengths of 2 […]
Lupin has received USFDA approval to market Lurasidone Hydrochloride tablets in US markets. The drug is used in the treatment of schizophrenia and will be […]
Aurobindo Pharma Ltd has received USFDA approval to market potassium chloride tablets of 600 mg and 750 mg in the US market. The tablet, a […]
Sun Pharmaceutical has received USFDA approval for Elepsia XR, an antiepileptic drug in US markets. The company has received this approval through one of its […]
Strides Pharma Science has received final USFDA approval to market laxative Polyethylene Glycol 3350 and Electrolytes for Oral Solution. The company has received this approval […]
Zydus Cadila has received final USFDA approval to market Doxycycline Hyclate delayed-release tablets which are used to treat bacterial infections. The drug will be marketed […]
Aurobindo Pharma has received final USFDA approval to manufacture and market Vecuronium Bromide Injection, 10mg and 20mg for the US markets. The drug Vecuronium Bromide […]
Copyright © 2024 | WordPress Theme by MH Themes